GSK, CEPI announce collaboration to develop coronavirus vaccine

British pharmaceutical giant GlaxoSmithKline (GSK) said on Monday that it is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) in effort to develop a vaccine for the coronavirus outbreak.

GSK will make adjuvant technology available to enhance the development of an effective vaccine against 2019-nCoV, according to the statement.